Indo Borax & Chemicals delivered a strong Q4 FY26, with consolidated revenue up 25.7% YoY to Rs 63.01 Cr and net profit soaring 41.9% YoY to Rs 14.53 Cr.

For the full year FY26, revenue grew 22.9% to Rs 215.45 Cr and PAT rose 18.3% to Rs 50.27 Cr.

This robust performance was fueled by improved capacity utilization, operational efficiencies, and steady domestic demand.

The company maintains healthy EBITDA (20.5%) and PAT (21.8%) margins, and declared a total dividend of Rs 40 per share for FY26. Strategically, Indo Borax is a leading Boric Acid player now expanding downstream into high-margin Disodium Octaborate Tetrahydrate (DOT) with a new 6,000 MTPA plant, leveraging its in-house raw material supply.

This aims to reduce import dependency and capture incremental domestic demand.

The new management, following a significant ownership transition in January, focuses on geographical expansion, operational optimization, and innovation-led growth.

Management is optimistic about 'Aatmanirbhar Bharat' and 'Make in India' initiatives, expecting sustainable growth.

The company is near-zero debt.